class="p">160

https://www.nature.com/articles/s41380–021–01091–4.

161

J. R. Whitwell, Historical Notes on Psychiatry. London: Lewis, 1936.

162

Andreasen NC. The relationship between creativity and mood disorders. Dialogues in Clinical Neuroscience. 2008; 10(2): 251–255

163

Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989; 52(2): 125–34

164

Ludwig AM. Creative achievement and psychopathology: comparison among professions. Am J Psychother. 1992; 46(3): 330–56

165

Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA. Enhanced creativity in bipolar disorder patients: a controlled study. J Affect Disord. 2007; 100(1–3): 31–9

166

Kyaga S, Lichtenstein P, Boman M, Hultman C, Långström N, Landén M. Creativity and mental disorder: family study of 300,000 people with severe mental disorder. Br J Psychiatry. 2011;199(5): 373–9

167

Frederick K. Googwin, Kay Redfield Jamison. Manic-depressive ilness. Bipolar disorders and reccurent depression. Oxford University Press 2007

168

Figueroa c G. [Virginia Woolf as an example of a mental disorder and artistic creativity]. Rev Med Chil. 2005; 133(11): 1381–8

169

Ta-Wei Guu, Kuan-Pin Su. Musical creativity and mood bipolarity in Robert Schumann: A tribute on the 200th anniversary of the composer's birth. Psychiatry and Clinical Neurosciences 2011; 65: 112–114

170

Stephen G. Michaud, Hugh Aynesworth. The Only Living Witness: The True Story of Serial Sex Killer Ted Bundy

171

M. Fink, Delirious mania. Bipolar Disorders, vol. 1, no. 1, pp. 54–60, 1999

172

Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry. 2010;67(9): 931–8.

173

https://www.psychologytoday.com/blog/inside-the-criminal-mind/201105/bipolar-illness-or-the-ups-and-downs-the-antisocial-persons

174

Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord. 1999; 52(1–3): 135–44

175

Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. The American journal of psychiatry. 2013; 170(11): 1249–1262. doi: 10.1176/appi.ajp.2013.13020185.

176

Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003; 160(12): 2099–107.

177

Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014; 75(3): 254–62

178

Baethge C, Baldessarini RJ, Mathiske-schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2): 174–82.

179

Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014; 2: 15. doi: 10.1186/s40345–014–0015–8.

180

Van der loos ML, Kölling P, Knoppert-van der klein EA, Nolen WA. [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr. 2007; 49(2): 95–103.

181

Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009; 61(2): 185–209.

182

Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.

183

Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1): 4–9.

184

Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi: 10.1186/s40345–014–0015–8.

185

Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194 (1): 4–9.

186

Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052

187

Ushkalova AV, Kostiukova EG, Mosolov SN. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(1 Vypusk 2 Depressiia): 23–30

188

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515925/#:~:text=Quetiapine%2C%20which%20is%20the%20first,the%20Canadian%20Network%20for%20Mood.

189

Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder?. Can J Psychiatry. 2007;5 2(1): 14–21

190

Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 1999;108(4): 579–87.

191

Miklowitz DJ. The Bipolar Disorder Survival Guide, Second Edition, What You and Your Family Need to Know. Guilford Press; 2011

192

Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012; 200(2–3):242–5

193

Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002; 4(3): 231–249.

194

Ohman A, Lundqvist D, Esteves F. The face